On 29 May 2017
Wintac will hold a meeting of the Board of Directors of the Company on 29 May 2017, for considering the audited financial results for the year ending 31.03.2017, to consider External Commercial Borrowings from the Promoter Company (GAVIS Pharma LLC, USA) for financing new Capex Requirements, and to consider proposal for implementation of Employees Stock Option Scheme.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)